Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Enterprisewide Molecules Developed by Biotech Companies per Therapeutic Class and Clinical Phase TriMark Publications, Sep 2006, Pages: 1   Description        Enquire before Buying    Send to a Friend   This Database Table is a one-page table of hard-to-find numerical information. Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors. Over 600 database tables are now available from Research and Markets. A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: Pharmaceuticals, Healthcare and Medical Devices, and Biotechnology. Customers who bought this item also bought Indian Biotech Industry (2005) BioTech Stock Report DNA Sequencing and PCR Markets Emerging U.S. Biopharmaceutical Companies: New Drug R&D and Investment / Partnership Opportunities Bioprocesses of Biopharmaceuticals - The Obligatory Role of Post Translational Modifications to Create Functional Bioactive Molecules Strategies And Tactics That Improve Patient Recruitment and Retention in Clinical Studies ADME in Children and The Elderly: Clinical Challenges and Opportunities US number of drugs in phase I development by biotechnology companies by therapeutic class; number of approved drugs in each class, ratio of approved drugs to investigational candidates, and number of biotech companies with phase I candidates, reporte

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster